David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
CALL
Jones Lang LaSalle
JLL
$17.8B
| $2.98M | ﹤0.01% |
15,800
+10,000
| +172% | +$1.51M |
|
2202
Hudbay
HBM
$13.3B
| $2.98M | ﹤0.01% |
541,502
-695,834
| -56% | -$3.26M |
|
2203
ImmunityBio
IBRX
$8.74B
| $2.97M | ﹤0.01% |
+591,101
| New | +$1.85M |
|
2204
Hims & Hers Health
HIMS
$6.96B
| $2.97M | ﹤0.01% |
333,293
-103,844
| -24% | -$768K |
|
2205
HUTCHMED
HCM
$2.15B
| $2.96M | ﹤0.01% |
163,606
+34,555
| +27% | +$628K |
|
2206
Kura Oncology
KURA
$1.16B
| $2.96M | ﹤0.01% |
205,620
-1,480
| -0.7% | -$14.6K |
|
2207
Century Aluminum
CENX
$4.35B
| $2.96M | ﹤0.01% |
243,476
-93,310
| -28% | -$732K |
|
|
AMWD
2208
DELISTED
American Woodmark
AMWD
| $2.95M | ﹤0.01% |
31,825
-20,766
| -39% | -$1.62M |
|
2209
Alliant Energy
LNT
$17.9B
| $2.95M | ﹤0.01% |
57,552
-120,236
| -68% | -$6M |
|
2210
US Foods
USFD
$23.5B
| $2.95M | ﹤0.01% |
64,964
-179,094
| -73% | -$7.41M |
|
|
WCC
2211
WESCO International
WCC
$16.9B
| $2.95M | ﹤0.01% |
16,962
-15,033
| -47% | -$2.25M |
|
2212
Clean Energy Fuels
CLNE
$357M
| $2.94M | ﹤0.01% |
767,691
-382,089
| -33% | -$1.39M |
|
2213
CryoPort
CYRX
$839M
| $2.94M | ﹤0.01% |
+189,565
| New | +$2.48M |
|
2214
CALL
iQIYI
IQ
$948M
| $2.93M | ﹤0.01% |
601,000
+231,000
| +62% | +$1.09M |
|
|
RRAC
2215
DELISTED
Rigel Resource Acquisition Corp.
RRAC
| $2.93M | ﹤0.01% |
+267,479
| New | +$2.93M |
|
|
CALY
2216
CALL
Callaway Golf Company
CALY
$2.81B
| $2.93M | ﹤0.01% |
204,300
+77,600
| +61% | +$997K |
|
2217
PDF Solutions
PDFS
$1.9B
| $2.93M | ﹤0.01% |
91,035
+6,372
| +8% | +$193K |
|
2218
Trustmark
TRMK
$2.69B
| $2.92M | ﹤0.01% |
104,753
-29,232
| -22% | -$678K |
|
2219
CALL
Burlington
BURL
$19.8B
| $2.92M | ﹤0.01% |
+15,000
| New | +$2.24M |
|
|
NPKI
2220
NPK International
NPKI
$1.12B
| $2.92M | ﹤0.01% |
439,298
-192,264
| -30% | -$1.34M |
|
2221
CALL
Rambus
RMBS
$9.76B
| $2.91M | ﹤0.01% |
42,700
| – | – |
|
2222
PUT
Helmerich & Payne
HP
$4.14B
| $2.91M | ﹤0.01% |
+80,400
| New | +$3.11M |
|
2223
Watts Water Technologies
WTS
$12.6B
| $2.91M | ﹤0.01% |
13,954
-11,619
| -45% | -$2.19M |
|
2224
DMC Global
BOOM
$136M
| $2.9M | ﹤0.01% |
154,331
-1,420
| -0.9% | -$26.1K |
|
2225
Trupanion
TRUP
$1.32B
| $2.9M | ﹤0.01% |
+94,983
| New | +$2.52M |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.